Monthly Archives: September 2017

State Department, PEPFAR release good news and a “strategy” short on details, definition

By on .

Names 13 countries for “particular focus” with aim for epidemic control by 2020 . . . Botswana, Côte d’Ivoire, Haiti, Kenya, Lesotho, Malawi, Namibia, Rwanda, Swaziland, Tanzania, Uganda, Zambia, Zimbabwe to be focus of efforts . . . Providing some clarification to proposals to shift the focus of the President’s Emergency Plan for AIDS Relief […]

Study suggests opening use of last resort TB drug for children

By on .

Researchers: bedaquiline can be used safely in MDR TB patients 12 and older, and should be considered for younger children The innovative anti-tuberculosis drug that represents a reprieve for adults whose disease does not respond to other treatments should also be made available to children aged 12 or older, according to findings from a study […]

What we’re reading: Insights on global health policy, and why, when funding doesn’t support disease-fighting goals, something’s got to give

By on .

Goalkeepers: The stories behind the data – A companion piece to the data-dense Lancet review of health-related goals for 2030  released Tuesday, the stories behind the data told here focus on policies and practices that are pushing progress — through patient-focused health services, targeted use of new technologies, and greater investments — now. While acknowledging […]

Global health data review finds no country on track to end TB incidence by 2030, vast majority of countries falling short of goals to control HIV

By on .

Projections based on  current burdens of disease, along with data from the preceding 26 years, show both vast inequalities of progress, as well as the likelihood of limited success across both wealthy and low-income countries in meeting specific goals to improve health care and health access around the world by 2030. The projections from a […]

Appropriators approve sustained global health, boost to TB, increased research funding, reject expanded global gag rule

By on .

“Now is not the time to back off,” Sen. Lindsay Graham (R-SC) Senate appropriators today approved spending for the coming fiscal year that would continue current funding levels for global health programs, add $2 billion to funding for the National Institutes of Health, including by maintaining the Fogarty International Center and its worldwide research and […]

Senate funding committees vote to boost NIH, global TB investments, maintain global and domestic health funding

By on .

Senate appropriators today rejected budget cuts proposed by the Trump administration and voted to increase funding for biomedical research at the National Institutes of Health by $2 billion while maintaining current funding for virtually all global and domestic health programs. With details on the particulars still sketchy, the funding subcommittee appears to have rejected cuts […]

What we’re reading: News from Africa includes a shortage of medicine in Zimbabwe, health worker shortage in Uganda, and a policy brings a cold blast from the past in Zambia . . .

By on .

South Africa: Take on government, challenge it to do more – As donors HIV dollars flatline, as if the hard part of fighting the pandemic is behind us, this op ed from South Africa Deputy President, and South African National AIDS Council co-chair Cyril Ramaphosa reminds his country, and the world, “there are still many […]

Study finds small savings, high costs in both dollars and lives from global HIV funding cuts

By on .

“We leave it to readers to draw their own conclusions about whether imposing such tradeoffs on vulnerable populations accurately reflects how donor countries value life in recipient nations . . .” Walensky et al, Annals of Internal Medicine, August 28, 2017 Cutbacks to HIV services driven by diminishing donor dollars would result in reductions of […]